Vial Introduces New Scientific Advisory Board Member, Roberta Brinton of The University of Arizona Health Sciences to Their Neurology CRO
Retrieved on:
Monday, October 17, 2022
SAN, Ophthalmology, EDC, Digital technology, Senate, Dermatology, Therapy, Woman of the Year, Vial, Science, Mathematics, Neurodegeneration, Biotechnology, Patient, Alzheimer's Drug Discovery Foundation, ESourcing Capability Model, Alzheimer's disease, Gastroenterology, Multimedia, STEM, Technology, United States Air Force Scientific Advisory Board, Society, Neurology, Presidential Citizens Medal, Drug discovery, CNS, News, 2020 California State Senate election, EPRO, Central nervous system, Center, U.S. News & World Report, Engineering, Hispanic Scientist of the Year Award, CRO, Fine chemical
SAN FRANCISCO, Oct. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Roberta Brinton as a new Central Nervous System (CNS) advisory board member.
Key Points:
- SAN FRANCISCO, Oct. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Roberta Brinton as a new Central Nervous System (CNS) advisory board member.
- In the neurology space, that is exactly the creative vision you need when developing new treatment methods," said Dr. Brinton on joining Vial's Scientific Advisory Board.
- Dr. Brinton will act as a founding scientific advisor to Vial's Neurology CRO to refine the CRO to support neurology sponsors' and patients' greatest needs.
- Vial operates across multiple therapeutic areas ( Dermatology CRO , Ophthalmology CRO , Oncology CRO , Gastroenterology CRO , and Neurology CRO ).